Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 2002 Feb;40(2):620–626. doi: 10.1128/JCM.40.2.620-626.2002

Molecular Profiles of Group B Streptococcal Surface Protein Antigen Genes: Relationship to Molecular Serotypes

Fanrong Kong 1, Sonia Gowan 2, Diana Martin 2, Gregory James 1, Gwendolyn L Gilbert 1,*
PMCID: PMC153396  PMID: 11825981

Abstract

The study of surface protein antigens of group B streptococci (GBS) is important for understanding of the pathogenesis and epidemiology of infection, and several of these antigens have been proposed as components of GBS conjugate vaccines. In a previous study, we developed a novel PCR-and-sequencing system for identification of GBS serotypes and serosubtypes based on the capsular polysaccharide synthesis (cps) gene cluster. In this study, we used published sequences to develop PCR assays for identification of genes encoding GBS surface proteins including C alpha (bca), C alpha-like proteins 2 and 3 (alp2 and alp3), Rib (rib), and C beta (bac). We showed that the prototype R reference strain, Prague 25/60, contained a novel alpha-like protein antigen gene (the proposed alp4), which presumably encodes an atypical, but antigenically similar, R-like protein. Initial evaluation of these gene-specific assays showed excellent specificity. By combining cps serotypes, serosubtypes, and surface protein gene profiles, we were able to divide 224 GBS isolates into 31 serovariants. GBS bac-positive strains could be further subtyped into 11 groups and 20 subgroups. Our results confirmed and extended reported associations between some cps serotypes and serosubtypes, on the one hand, and surface protein genes, on the other: serosubtypes III-1 and III-2 were associated with rib, serosubtype III-3 with alp2, serotype Ib with bca and bac, and serotype V with alp3. The associations between serotype Ia and bca, bca repetitive unit, and bca repetitive unit-like sequence-containing genes need to be studied further. These PCR-based methods will provide an alternative and objective tool for subtyping of GBS based on surface protein antigen genes.


Group B streptococci (GBS)—Streptococcus agalactiae—are the commonest cause of neonatal and obstetric sepsis and an increasingly important cause of septicemia in the elderly and in immunocompromised patients (25). There are nine GBS capsular polysaccharide serotypes (based on the capsular polysaccharide synthesis [cps] gene cluster), which vary in their distribution among geographic areas, disease types, and patient age groups (5, 8). Capsular polysaccharides are important virulence factors and epidemiological markers and are the main components of conjugate vaccines. For studies of epidemiology and pathogenesis, it is important to identify as many phenotypic or molecular markers as possible to increase the discriminatory power of typing systems (6). In addition to capsular polysaccharide antigens, GBS surface protein antigens, which also contribute to the pathogenesis of GBS disease and induce protective immunity, are potentially useful markers (16). Their use in polysaccharide conjugate vaccines is under investigation (4, 17). Identification of surface protein antigens, combined with cps serotyping, allows subdivision of GBS strains into a large number of serovariants, which can facilitate epidemiological, pathogenetic, and other related studies of GBS infection (15).

The genes encoding the C alpha protein (bca), C alpha-like proteins 2 and 3 (alp2 and alp3), and the Rib protein (rib) have been well studied, and their gene sequences have been published in GenBank (16, 23, 29). They are members of a family of surface proteins containing repetitive elements, which produce variations in protein size and antigenicity (16, 29). The gene encoding the C beta or IgA binding protein (bac) has also been well described (7, 9). C alpha, C beta, and Rib proteins have all been proposed as potential vaccine components (17, 18, 22).

Numerous methods have been used to identify GBS surface antigens by using monoclonal (24) or polyclonal antibodies (3) or genes by hybridization with probes (27), PCR (19, 20, 21), and/or sequencing (16, 20). PCR-based methods are attractive because of their high discriminatory power and reproducibility (20). PCR methods to detect C alpha and C beta protein genes have been published (19, 20, 21), but the specificity, clinical application, and interpretation of these methods require further study. Specific PCR methods to identify genes encoding Rib and C alpha-like proteins 2 and 3, which are present in the more-virulent serotypes, III and V, have not yet been described (16, 29). Associations between cps serotypes and some protein antigens have been described (15, 27). They are likely to vary over time and in different populations and geographic locations (5, 8) and should be useful for studies of the epidemiology and pathogenesis of GBS infection.

In this study, we used published sequences of surface protein antigen genes, including bca, bac, alp2, alp3, and rib (7, 9, 16, 23, 29), to improve and/or develop protein gene-specific PCR assays. We used these assays to examine the distribution and variation of surface protein genes, and their associations with cps genes, in a large collection of GBS isolates collected over the past decade in Australia and New Zealand.

MATERIALS AND METHODS

GBS isolates, serotyping, and serosubtyping.

The isolates used in this study and the serotype and serosubtype identification methods have been described in detail elsewhere (14). Isolates included well-characterized reference panels kindly provided by Lawrence Paoletti, Channing Laboratory, Boston, Mass. (serotypes Ia to VIII; reference panel 1), and Diana Martin, Streptococcus Reference Laboratory, Institute of Environmental Science and Research, Porirua, Wellington, New Zealand (serotypes Ia to VI; reference panel 2), and 206 clinical isolates. All isolates were serotyped by conventional and molecular methods, and some were serosubtyped by PCR and sequencing. Antisera used for serotyping were prepared against serotypes Ia, Ib, Ic, and II through VIII and against the R protein antigen. The prototype R reference strain Prague 25/60 was used to raise the R antiserum.

Oligonucleotide primers.

Oligonucleotide primers used in this study, their target sites in the gene sequences, and their melting temperatures (Tm) are shown in Table 1. The primers were synthesized according to our specifications by Sigma-Aldrich (Castle Hill, New South Wales, Australia). Six previously published oligonucleotide primers (19, 20, 21) and a series of new primers designed by us were used to sequence parts of genes encoding GBS surface proteins and/or to specifically amplify these genes. All new primers, except two used only for sequencing rib and six previously published (unmodified), were designed with high Tm (>70oC) for use in rapid-cycle PCR (Table 1).

TABLE 1.

Oligonucleotide primers used in this study

Primer reference Target gene(s) Tm (°C)a GenBank accession no. Sequenceb
IgAagGBSc bac 73.8 X59771 2663GCGATTAAACAA CAA ACT ATT TTT GAT A TTG ACA ATG CAA2702
IgAS1d bac 72.8 X59771 2765GCT AAA TTT CAA AAA GGT CTA GAG ACA AAT ACG CCA G2801
IgAA1d bac 78.9 X59771 3157CCC ATC TGG TAA CTT CGG TGC ATC TGG AAG C3127
RigAagGBSc bac 76.3 X59771 3284CAGCCAACTCTTTC GTC GTT ACT TCC TTG AGA TGT AAC3247
GBS1360Se bac 72.3 X59771 1325GTGAAATTGTAT AAG GCT ATG AGT GAG AGC TTG GAG1360
GBS1717Sd bac 75.0 X59771 1685ACA GTC ACA GCT AAA AGT GAT TCG AAG ACG ACG1717
GBS1937Ae bac 75.9 X59771 1976CCGTTTTAGAATCTTT CTG CTC TGG TGT TTT AGG AAC TTG1937
BcaRUSf bca repetitive unit 73.5 M97256 769GATAAATATGATCCAA CAG GAG GGG AAA CAA CAG TAC805
BcaRUAf bca repetitive unit 77.2 M97256 1003CTGGTTTTGGTGTCACAT GAA CCG TTA CTT CTA CTG TAT CC963
bcaS1d bca, alp2, alp3 71.7 M97256 and AF291065 208/533GGT AAT CTT AAT ATT TTT GAA GAG TCA ATA GTT GCT GCA TCT AC251/576
bcaS2d bca, alp2, alp3 78.0 M97256 and AF291065 256/581CCAGGGA GTG CAG CGA CCT TAA ATA CAA GCA TC288/613
balSd alp2, alp3 73.8 AF291065 677GAT CCT CAA AAC CTC ATT GTA TTA AAT CCA TCA AGC TAT TC717
bcaAd bca 74.2 M97256 597CGTTCTAACTT CTT CAA TCT TAT CCC TCA AGG TTG TTG560
balAd alp2, alp3 73.6 AF291065 978CCA GTT AAG ACT TCA TCA CGA CTC CCA TCA C948
bal23S1d alp2, alp3 70.9 AF208158 and AF291065 1093/1373CAG ACT GTT AAA GTG GAT GAA GAT ATT ACC TTT ACG G1129/1409
bal23S2d alp2, alp3 72.9 AF208158 and AF291065 1174/1454CTT AAA GCT AAG TAT GAA AAT GAT ATC ATT GGA GCT CGT G1213/1493
bal2A1d alp2 78.3 AF208158 1426CGT GTT GTT CAA CAG TCC TAT GCT TAG CCT CTG GTG1391
bal2A2d alp2 70.8 AF208158 1518GGT ATC TGG TTT ATG ACC ATT TTT CCA GTT ATA CG1484
bal3Ad alp3 79.2 AF291065 1693GAC CGT TTG GTC CTT ACC TTT TGG TTC GTT GCT ATC C1657
ribS1d,g rib 65.2 U58333 216TAC AGA TAC TGT GTT TGC AGC TGA AG241
ribS2d rib 73.0 U58333 238GAAGTAATTTCAG GAA GTG CTG TTA CGT TAA ACA CAA ATA TG279
ribA1d rib 78.8 U58333 431GAA GGT TGT GTG AAA TAA TTG CCG CCT TGC CTA ATG396
ribA2d rib 72.6 U58333 462AAT ACT AGC TGC ACC AAC AGT AGT CAA TTC AGA AGG427
ribA3d,g rib 61.3 U58333 570CAT CTA TTT TAT CTC TCA AAG CTG AAG554
a

Primer Tm values were provided by the primer synthesizer (Sigma-Aldrich).

b

Numbers (in boldface) represent base positions at which primer sequences start and finish, taking the start point(s) of the corresponding GenBank accession number(s) as 1. Underlined sequences are bases added to modify previously published primers.

c

From reference 21.

d

Primers designed by us for this study.

e

From reference 19.

f

From reference 20.

g

For sequencing use only; not entirely specific for the rib gene.

DNA preparations and PCR.

DNA was prepared from GBS cultures (21), and PCR was performed as previously described (11, 12, 14). Denaturation, annealing, and elongation temperatures and times used were 96°C for 1 s, 45 to 72°C (according to the primer Tm or as previously described) for 1 s, and 74°C for 1 to 30 s (according to the length of amplicons), respectively, for 30 to 35 cycles, using a Perkin-Elmer Thermal Cycler 9600. Ten microliters of PCR products was analyzed by electrophoresis on 1.5% agarose gels, which were stained with 0.5 μg of ethidium bromide ml−1. For detection and/or subtyping, the presence of PCR amplicons of the expected lengths, shown by UV transillumination, was accepted as positive. For sequencing, 40-μl volumes of PCR products were further purified by the polyethylene glycol precipitation method (1).

Sequencing.

To confirm the specificity of newly designed or modified primer pairs, we sequenced 10, 13, and 10 selected amplicons produced by bcaS1-bcaA (targeting the 5" end of bca), ribS1-ribA3 (targeting rib), and GBS1360S-GBS1937A (targeting bac), respectively, from the two panels of reference strains and 31 randomly selected clinical isolates. All amplicons of primer pairs bcaS1-balA (targeting alp2 and alp3), bal23S1-bal2A2 (targeting alp2), and IgAagGBS-RIgAagGBS (targeting bac) from any of the 224 isolates were sequenced.

PCR products were sequenced using Applied Biosystems Taq DyeDeoxy terminator cycle-sequencing kits according to standard protocols. The corresponding amplification primers or inner primers were used as the sequencing primers.

Database similarity searching and sequence comparison.

Databases were searched for sequence similarity by using the FastA program in the SeqSearch program group. Sequences were compared using the Bestfit and Gap programs in the Comparison program group. The Translate program in the Translation program group was used to translate from DNA sequences to amino acid sequences. All programs are provided in WebANGIS (Australian National Genomic Information Service), version 3.

Surface protein gene profile codes.

Each isolate was given a protein gene profile code according to positive PCR results using various primer pairs, as shown in Table 2.

TABLE 2.

Specificity and expected lengths of amplicons of using different primer pairs

Primer paira Specificity Length of amplicon (bp) Protein gene profile code(s)c
IgAagGBS-RIgAagGBS bac 532-838 B
IgAS1-IgAA1 bac 303-591 B
GBS1360S-GBS1937A bac 652 B
GBS1717S-GBS1937A bac 292 B
bcaS1-bcaA 5" end of bca 390 A
bcaS2-bcaA 5" end of bca 342 A
BcaRUS-BcaRUA bca repetitive unit, bca repetitive unit-like region 235 a or as
bcaS1-balA alp2, alp3 446 alp2 or alp3
bcaS2-balA alp2, alp3 398 alp2 or alp3
balS-balA alp2, alp3 302 alp2 or alp3
bal23S1-bal2A1 alp2 334 alp2
bal23S2-bal2A1 alp2 253 alp2
bal23S1-bal2A2 alp2 426 alp2
bal23S2-bal2A2 alp2 345 alp2
bal23S1-bal3A alp3 321 alp3
bal23S2-bal3A alp3 240 alp3
ribS1-ribA3b rib 355 R or alp4
ribS2-ribA1 rib 194 R
ribS2-ribA2 rib 225 R
ribS2-ribA3 rib 333 R
a

See Table 1 for primer sequences. For primer pair ribS1-ribA3, the annealing temperature used was 55 to 60°C. For three previously described primer pairs (unmodified), annealing temperatures were as described previously (19, 20, 21), and for all other new primer pairs, they were 68 to 72°C (according to the Tm).

b

For sequencing use only; not entirely specific for the rib gene (see the text for more detail).

c

See Table 4 footnotes for explanation of protein gene profile codes.

Nucleotide sequence accession numbers.

The sequences generated during this study have appeared in GenBank with the following accession numbers: AF367974 (partial bac sequence, with an insertion sequence, IS 1381, from one isolate), AF362685 to AF362704 (partial bac sequences for all bac-positive isolates), and AF373214 (partial proposed new alpha-like protein 4 gene [alp4] for reference strain Prague 25/60, an R protein standard strain).

Previously published gene sequences used in this study and their GenBank accession numbers are as follows: M97256 (bca), X58470 and X59771 (bac), U58333 (rib), AF208158 (alp2), AF291065 to AF291072 (alp3), and AF064785 (IS1381).

RESULTS

PCR results.

With few exceptions, all primer pairs produced amplicons of the predicted lengths from isolates giving positive results (Table 2). Figure 1 shows a representative gel. The exceptions included one isolate that was positive by PCR using primer pairs GBS1360S-GBS1937A and GBS1717S-GBS1937A (both targeting bac) but produced amplicons significantly longer than those of other bac-positive isolates. Sequencing showed that the amplicon contained the insertion sequence IS1381 with minor variations from the published sequences (28). The amplicons produced using primers IgAagGBS-RIgAagGBS and IgAS1-IgAA1 (also targeting bac) varied in length (2) and were sequenced for further subtyping (see below and Table 3).

FIG. 1.

FIG. 1.

Results of PCR amplification using the primer pair bcaS2-bcaA (targeting and specific for the 5" end of bca). Lanes M, molecular weight marker φX174 DNA/HinfI; lanes 1 to 7, seven serotype Ia isolates, one of which (lane 4) was positive for the 5" end of bca; lanes 8 to 14, seven serotype II isolates, three of which (lanes 10, 12, and 13) were positive for the 5" end of bca.

TABLE 3.

Genetic groups and subgroups of bac (C beta protein gene) based on amplicon length (using primers IgAagGBS and RIgAagGBS) and sequence heterogeneity

Group or subgroup (n) Amplicon length (bp) GenBank accession no. No. of sites different from main groupa Molecular serotype(s) or serosubtypesb (n)
B1 (19) 532 AF362685c Ib (17), II (2)
B1a (1) 532 AF362686 1 (B1) Ib
B2 (3) 550 AF362687 Ib, II, III-4
B3 (2) 586 AF362688 Ib (2)
B3a (1) 586 AF362689 4 (B3) V
B3b (1) 586 AF362690 21 (B3) VI
B3c (1) 586 AF362691 24 (B3) Ib
B4 (8) 604 AF362692 Ib (4), II (4)
B4a (1) 604 AF362693 1 (B4) II
B4b (2) 604 AF362694 2 (B4) Ib (2)
B5 (2) 622 AF362695d Ia, VI
B5a (1) 622 AF362696 2 (B5) Ia
B6 (1) 640 AF362697 Ib
B7 (1) 658 AF362698 Ib
B7a (1) 658 AF362699 34 (B7) VI
B8 (1) 712 AF362700 Ib
B9 (2) 748 AF362701 II (2)
B9a (1) 748 AF362702 13 (B9) Ib
B10 (2) 820 AF362703 Ib (2)
B11 (1) 838 AF362704 Ib
a

The main group is shown in parentheses.

b

See Table 4 for further details of cps serotype and serosubtype relationships with protein antigen genes.

c

The AF362685 sequence is identical with the corresponding portion of X58470.

d

The AF362695 sequence is identical with the corresponding portion of X59771.

Evaluation of the protein gene-specific primer pairs by direct sequencing of PCR amplicons.

All 10 amplicons of primer pair bcaS1-bcaA and 12 of 13 amplicons (except that from strain Prague 25/60 [see below]) of primer pair ribS1-ribA3 were identical with the corresponding portions of the gene sequences in GenBank (M97256 [bca] and U58333 [rib], respectively). Four of 10 amplicons of primer pair GBS1360S-GBS1937A (targeting bac) were identical with the corresponding gene sequence in GenBank (X58470, X59771). A single point mutation (A to G at position 1441 of X59771) was found in the remaining six bac-positive amplicons, including the one that contained the insertion sequence IS1381 (see above and GenBank accession number AF367974).

Fifty isolates produced amplicons with primer pair bcaS1-balA. The sequences of 9 were identical with the corresponding portion of the published sequence of alp2 (AF208158), and those of 41 were identical with that of alp3 (AF291065). There are two consistent heterogeneity sites between alp2 and alp3 in the sequences of bcaS1-balA amplicons, which can be used to distinguish them, in addition to alp2- and alp3-specific PCR. All nine amplicons obtained with primer pair bal23S1-bal2A2 were identical with the corresponding portion of the alp2 sequence in GenBank (AF208158). Primer pair IgAagGBS-RIgAagGBS identified bac in 52 isolates. There was considerable sequence variation, which allowed separation of bac-positive isolates into 11 groups and 20 subgroups based on amplicon length and sequence heterogeneity, respectively (Table 3). The groups contained small numbers (1 to 5) of isolates except for B1 (20 isolates, 2 subgroups) and B4 (11 isolates, 3 subgroups). In general, the presence or absence of short repetitive sequences was responsible for differences in amplicon length (2, 9).

Further confirmation of specificity of surface protein gene-specific primer pairs.

To confirm primer pair specificity, we compared the results of PCR using the primer pairs we had designed or modified for bac PCR with those of PCR using previously published primer pairs (19, 21) and found 100% correlation.

The previously reported nonspecificity of the published primer pair bcaRUS-bcaRUA (targeting the bca repetitive unit) was confirmed (20). When these primers were used, all nine alp2-positive (BcaS1-BcaA-negative) isolates and 53 isolates which were PCR negative with primer pairs bcaS1-bcaA and bcaS2-bcaA (targeting the 5" end of bca) and with primer pairs bal23S1-bal2A2 and bal23S2-bal2A1 (targeting the 5" end of alp2) produced amplicons. Our sequencing showed that bca and alp2 have significant homology in the regions targeted by bcaRUS-bcaRUA, allowing amplicon formation from alp2-positive strains (16, 20). These false positive results could be due to the presence of other C alpha-like protein genes, containing regions homologous with the bca repetitive unit (bca repetitive unit-like sequence).

We also showed that the results of PCR using two or more primer pairs that we had designed for individual genes (rib, alp2, and alp3) correlated well, supporting the specificity of each set. The only exception, as mentioned above, was ribS1-ribA3, which produced a nonspecific amplicon from 1 of 224 isolates tested.

Prague 25/60 contains another new alpha-like surface protein antigen gene, alp4 (proposed).

Strain Prague 25/60 (which is used to raise the R antiserum), in reference panel 2, produced an amplicon with primer pair ribS1-ribA3 but not with ribS2-ribA1, ribS2-ribA2, or ribS2-ribA3. It was therefore assumed not to contain rib, although the amplicon sequence showed considerable homology with rib and other members of the family of surface proteins (see below). This isolate was the only one, of 224 tested, for which PCRs were negative using ribS2-ribA1 and ribS2-ribA2 but positive using ribS1-ribA3. The latter primer pair is, then, not entirely specific for rib and was therefore used only for sequencing.

Sequencing of the Prague 25/60 ribS1-ribA3 amplicon showed considerable homology with other members of the surface protein gene family defined by bca-rib. The homologous regions were located at the 5" ends of the genes (for bca, the positions are in the region between nucleotides 251 and 559, and for the corresponding amino acid sequence, they are between positions 58 and 160 of the sequence identified by GenBank accession number M97256). The ratios of similarity (excluding the primer sequences) to DNA sequences of bca, rib, alp2, and alp3 were 66.7, 64.4, 62.5, and 62.5%, respectively. For the corresponding amino acid sequences, similarity ratios were 62.1, 60.2, 57.3, and 57.3%, respectively. Since this amplicon sequence is most similar to that of bca, which encodes C alpha, the prototype of the surface protein family, we propose that the gene be named alp4 (C alpha-like protein antigen 4 gene). Cloning and sequencing of the whole gene were beyond the scope of this study.

Surface protein gene profiles.

For each GBS surface protein gene (except the bca repetitive unit and bca repetitive unit-like region), we selected two primer pairs to identify and characterize it by PCR. Four common profiles accounted for 203 of 224 (90.6%) isolates: R (62 isolates), AaB (51 isolates), a (49 isolates), and alp3 (41 isolates) (see Table 4). Only two isolates contained no surface protein gene markers. All but one isolate with the bac gene (B) also had bca with its repetitive unit (Aa); one had rib (R). All alp2 isolates contained single bca repetitive unit-like sequences (as). A, R, alp2, alp3, and the proposed new protein type alp4 were all mutually exclusive. Sixty-two of 63 isolates with rib (R) and 41 of 41 isolates with alp3 had no other protein antigen gene markers.

TABLE 4.

Relationships between GBS protein gene profiles and capsular polysaccharide synthesis (cps) gene molecular serotypes and serosubtypes

Serotype or serosubtypea (n) No. of isolates with surface protein gene profileb:
None Aa AaB R alp3 a as alp2as RB alp4a
Ia (43) 2 35 3 3
Ib (37) 1 35 1
II (29) 3 10 8 2 5 1c
III-1 (30) 30
III-2 (22) 22
III-3 (5) 5
III-4 (3) 1 1 1
IV (9) 1 8
V (38) 1 1 35 1
VI (5) 1 3 1
VII (1) 1
VIII (2) 1 1
Total (224) 2 5 51 62 41 49 3 9 1 1
a

See the text for an explanation of cps serosubtypes (14).

b

Protein antigen gene profile codes are as follows: A, 5" end of bca positive; a or as, bca repetitive unit or bca repetitive unit-like region positive, with multiple- or single-band amplicons, respectively; B, bac positive; R, rib positive; alp2, alp2 positive; alp3, alp3 positive.

c

This isolate was the atypical reference strain Prague 25/60, which was nonserotypeable using capsular polysaccharide antisera but was assigned to molecular serotype II. It expresses a protein that is antigenically similar to R (and is used to generate an R antiserum), for which we propose the name “alpha-like protein 4,” encoded by the “alp4” gene.

Relationship between surface protein antigen gene profiles and cps serotypes and serosubtypes.

Development of the molecular serotype (MS) identification method and comparison with conventional serotyping (CS) have been described elsewhere (14). A cps MS was assigned to all isolates, and the results correlated with CS results except for 19 of 224 isolates that were nontypeable by use of antisera. Relationships between surface protein gene profiles and cps molecular serotypes are summarized in Table 4.

The following strong associations were confirmed or demonstrated: MS Ia with bca repetitive unit or bca repetitive unit-like sequence (most with profile a), MS III-1 and III-2 with rib, MS III-3 with alp2, MS Ib with bca and bac, and MS V with alp3. MS II showed the most varied surface protein gene profiles. However, the relationships were not absolute, and different combinations of polysaccharide cps serotypes and protein gene profiles produced 31 serovariants, or 51 when bac (B) subgroups were considered.

Relationship between surface protein antigens and protein gene profiles.

Based on CS, 33 isolates (belonging to CS Ia/c, Ib/c, IIc, IIb, IIIc, or IIIb) reacted with the C antiserum. The surface protein gene profiles of all of these isolates included bca (A) and/or bca repetitive unit-related (a or as) markers as follows: Aa (3 isolates), AaB (18 isolates), a (11 isolates), and alp2as (1 isolate). Twenty-nine isolates reacted with the R antiserum; of these, 22 contained rib and 6 contained alp3. The remaining isolate was Prague 25/60 (the reference strain used to raise the R protein antiserum), which contained the new presumed alpha-like protein 4 gene, alp4 (see above).

DISCUSSION

In our previous study, all the isolates used in the present study were serotyped by conventional and molecular methods that identified their cps serotypes and, in some cases, serosubtypes (14). In this study we developed PCR-based methods to identify GBS surface protein genes and further characterize these isolates. Using the published bac sequence, we modified bac-specific primers (19, 21) and designed new primers, with high Tm (>70oC), suitable for rapid-cycle PCR (10, 13) and targeting all major surface protein genes.

As previously reported, a published PCR primer pair targeting the bca repetitive unit (at the 3" end of bca) was not entirely specific for bca (20). We designed two new primer pairs targeting the 5" end of bca in order to improve the specificity. However, very few serotype Ia strains gave positive results with these two primer pairs, whereas all were PCR positive using a primer pair targeting the bca repetitive unit (20). These results were consistent with a previous report (6) that a probe targeting the 5" end of bca hybridized with only one of nine serotype Ia strains, whereas a large bca probe, including the tandem repeat region, hybridized with all nine. Further study is required to define the sequences and specificities of different portions of bca and their effects, if any, on the structure and functions of C alpha and related proteins.

PCR primers specific for rib, alp2, and alp3 have not been described previously. The primer pairs we designed mainly targeted the 5" ends of the genes and were chosen after comparison of their heterogeneity with related gene sequences (16, 29). We designed two or more primer pairs for each gene in order to check primer specificity by comparing the results of different PCRs targeting the same genes. Protein gene profiles alp2 and alp3 were distinguished on the basis of the alp2- and alp3-specific PCR and/or two sequence heterogeneity sites in the amplicons of bcaS1-balA or bcaS2-balA.

To confirm the specificities of our primers, we used them to examine two reference panels and selected GBS isolates. The longest amplicons produced by PCR for each gene were sequenced in order to provide maximal sequence information and ensure that the inner primers were not located at strain heterogeneity sites. Our sequencing results confirmed the specificities of the primers. Two pairs of primers for each gene were compared, with similar results. Finally, six gene- or region-specific primer pairs (including the one targeting the bca repetitive unit) were used to define protein antigen gene profiles for all 224 isolates.

The study showed that only one member of the surface protein gene family containing repetitive sequences—rib, bca, alp2, or alp3 (or, presumably, alp4)—was present in any single isolate (15, 16). However, all isolates containing bac, which is not a member of the surface protein gene family containing repetitive sequences, also contained either bca (51 of 52 isolates) or rib (1 of 52 isolates) (15).

The C beta protein gene, bac, was present in 23% of isolates, a proportion similar to those (19 to 22%) previously reported (2). In common with others, we found variations in the bac (2) amplicons due to variable small internal repetitive sequences (2, 9) that, unlike those of the bca-rib family, were irregular. Their role is not clear, but they are potentially useful molecular markers for epidemiological studies (2, 7).

Our study confirmed previously reported relationships between cps serotypes and surface protein gene profiles (16). For example, some serotype III isolates (our MS III-1 and III-2) were closely associated with rib (26), and others (our MS III-3) were closely associated with alp2 (16). Serotype Ib was associated with bca and bac (15), and serotype V was associated with alp3 (16). However, as the relationship was not absolute, different combinations of cps serotypes and protein gene profiles identified many serovariants, which will be useful in epidemiological studies and in the formulation of conjugate vaccines (15, 16). Based on PCR only, we were able to divide our 224 isolates into 31 serovariants based on bac (B) groups or into 51 serovariants, based on subgroups. Theoretically, there are likely to be additional serovariants.

Comparison of protein antigen (C and R proteins) serotyping results with protein gene profiles showed that the presence of the gene does not necessarily indicate the expression of the corresponding protein. This is one reason for discrepancies between genetic and serotyping results; another is that C and R protein antisera are not entirely specific (16). Our analysis showed that reaction with the C antiserum generally correlated with the presence of genes encoding C alpha (bca) or alpha-like protein 2 (alp2). Reaction with the R antiserum correlated with the presence of genes encoding Rib protein (rib), alpha-like protein 3 (alp3), or the presumed new, rare alpha-like protein 4 (alp4) (found in this study). Apparently, antigenic cross-reactivity does not necessarily reflect genetic similarity, since the alp4 sequence studied was more similar to that of bca than to that of rib or alp3. More-extensive analysis of these genes and the relationships between the proteins they encode is required.

These methods will be useful in further studies of the effects of various antigen profiles on virulence and to further define the genealogy of GBS serotypes and various subtypes.

Acknowledgments

We thank Ansuiya Sharma, Rebecca Hoile, Leanne Montgomery, and David Smith for their help in culturing GBS strains, Moana Ngatai and Julie Morgan for serotyping of some isolates, and Mark Wheeler for valuable help in sequencing.

REFERENCES

  • 1.Ahmet, Z., P. Stanier, D. Harvey, and D. Holt. 1999. New PCR primers for the sensitive detection and specific identification of group B beta-hemolytic streptococci in cerebrospinal fluid. Mol. Cell. Probes 13:349-357. [DOI] [PubMed] [Google Scholar]
  • 2.Berner, R., A. Bender, C. Rensing, J. Forster, and M. Brandis. 1999. Low prevalence of the immunoglobulin-A-binding beta antigen of the C protein among Streptococcus agalactiae isolates causing neonatal sepsis. Eur. J. Clin. Microbiol. Infect. Dis. 18:545-550. [DOI] [PubMed] [Google Scholar]
  • 3.Bevanger, L., A. I. Kvam, and J. A. Maeland. 1995. A Streptococcus agalactiae R protein analysed by polyclonal and monoclonal antibodies. APMIS 103:731-736. [DOI] [PubMed] [Google Scholar]
  • 4.Gravekamp, C., D. L. Kasper, L. C. Paoletti, and L. C. Madoff. 1999. Alpha C protein as a carrier for type III capsular polysaccharide and as a protective protein in group B streptococcal vaccines. Infect. Immun. 67:2491-2496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Harrison, L. H., J. A. Elliott, D. M. Dwyer, J. P. Libonati, P. Ferrieri, L. Billmann, and A. Schuchat. 1998. Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. Maryland Emerging Infections Program. J. Infect. Dis. 177:998-1002. [DOI] [PubMed] [Google Scholar]
  • 6.Hauge, M., C. Jespersgaard, K. Poulsen, and M. Kilian. 1996. Population structure of Streptococcus agalactiae reveals an association between specific evolutionary lineages and putative virulence factors but not disease. Infect. Immun. 64:919-925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Heden, L. O., E. Frithz, and G. Lindahl. 1991. Molecular characterization of an IgA receptor from group B streptococci: sequence of the gene, identification of a proline-rich region with unique structure and isolation of N-terminal fragments with IgA-binding capacity. Eur. J. Immunol. 21:1481-1490. [DOI] [PubMed] [Google Scholar]
  • 8.Hickman, M. E., M. A. Rench, P. Ferrieri, and C. J. Baker. 1999. Changing epidemiology of group B streptococcal colonization. Pediatrics 104:203-209. [DOI] [PubMed] [Google Scholar]
  • 9.Jerlstrom, P. G., G. S. Chhatwal, and K. N. Timmis. 1991. The IgA-binding beta antigen of the c protein complex of group B streptococci: sequence determination of its gene and detection of two binding regions. Mol. Microbiol. 5:843-849. [DOI] [PubMed] [Google Scholar]
  • 10.Ke, D., C. Menard, F. J. Picard, M. Boissinot, M. Ouellette, P. H. Roy, and M. G. Bergeron. 2000. Development of conventional and real-time PCR assays for the rapid detection of group B streptococci. Clin. Chem. 46:324-331. [PubMed] [Google Scholar]
  • 11.Kong, F., X. Zhu, W. Wang, X. Zhou, S. Gordon, and G. L. Gilbert. 1999. Comparative analysis and serovar-specific identification of multiple-banded antigen genes of Ureaplasma urealyticum biovar 1. J. Clin. Microbiol. 37:538-543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Kong, F., G. James, Z. Ma, S. Gordon, B. Wang, and G. L. Gilbert. 1999. Phylogenetic analysis of Ureaplasma urealyticum--support for the establishment of a new species, Ureaplasma parvum. Int. J. Syst. Bacteriol. 49:1879-1889. [DOI] [PubMed] [Google Scholar]
  • 13.Kong, F., S. Gordon, and G. L. Gilbert. 2000. Rapid-cycle PCR for detection and typing of Mycoplasma pneumoniae in clinical specimens. J. Clin. Microbiol. 38:4256-4259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Kong, F., S. Gowan, D. Martin, G. James, and G. L. Gilbert. 2002. Serotype identification of group B streptococci by PCR and sequencing. J. Clin. Microbiol. 40:216-226. [DOI] [PMC free article] [PubMed]
  • 15.Kvam, A. I., A. Efstratiou, L. Bevanger, B. D. Cookson, I. F. Marticorena, R. C. George, and J. A. Maeland. 1995. Distribution of serovariants of group B streptococci in isolates from England and Norway. J. Med. Microbiol. 42:246-250. [DOI] [PubMed] [Google Scholar]
  • 16.Lachenauer, C. S., R. Creti, J. L. Michel, and L. C. Madoff. 2000. Mosaicism in the alpha-like protein genes of group B streptococci. Proc. Natl. Acad. Sci. USA 97:9630-9635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Larsson, C., M. Stålhammar-Carlemalm, and G. Lindahl. 1996. Experimental vaccination against group B streptococcus, an encapsulated bacterium, with highly purified preparations of cell surface proteins Rib and α. Infect. Immun. 64:3518-3523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Madoff, L. C., J. L. Michel, E. W. Gong, A. K. Rodewald, and D. L. Kasper. 1992. Protection of neonatal mice from group B streptococcal infection by maternal immunization with beta C protein. Infect. Immun. 60:4989-4994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Maeland, J. A., O. G. Brakstad, L. Bevanger, and A. I. Kvam. 1997. Streptococcus agalactiae beta gene and gene product variations. J. Med. Microbiol. 46:999-1005. [DOI] [PubMed] [Google Scholar]
  • 20.Maeland, J. A., O. G. Brakstad, L. Bevanger, and S. Krokstad. 2000. Distribution and expression of bca, the gene encoding the c alpha protein, by Streptococcus agalactiae. J. Med. Microbiol. 49:193-198. [DOI] [PubMed] [Google Scholar]
  • 21.Mawn, J. A., A. J. Simpson, and S. R. Heard. 1993. Detection of the C protein gene among group B streptococci using PCR. J. Clin. Pathol. 46:633-636. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Michel, J. L., L. C. Madoff, D. E. Kling, D. L. Kasper, and F. M. Ausubel. 1991. Cloned alpha and beta C-protein antigens of group B streptococci elicit protective immunity. Infect. Immun. 59:2023-2028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Michel, J. L., L. C. Madoff, K. Olson, D. E. Kling, D. L. Kasper, and F. M. Ausubel. 1992. Large, identical, tandem repeating units in the C protein alpha antigen gene, bca, of group B streptococci. Proc. Natl. Acad. Sci. USA 89:10060-10064. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Moyo, S. R., J. A. Maeland, and L. Bevanger. 1999. Comparison of three different methods in monoclonal antibody-based detection of Streptococcus agalactiae protein serotype markers. APMIS 107:263-269. [DOI] [PubMed] [Google Scholar]
  • 25.Schuchat, A. 1999. Group B streptococcus. Lancet 353:51-56. [DOI] [PubMed] [Google Scholar]
  • 26.Stalhammar-Carlemalm, M., L. Stenberg, and G. Lindahl. 1993. Protein rib: a novel group B streptococcal cell surface protein that confers protective immunity and is expressed by most strains causing invasive infections. J. Exp. Med. 177:1593-1603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Suvorov, A., A. Dmitriev, I. Ustinovitch, C. Schalen, and A. A. Totolian. 1997. Molecular analysis of clinical group B streptococcal strains by use of alpha and beta gene probes. FEMS Immunol. Med. Microbiol. 17:149-154. [DOI] [PubMed] [Google Scholar]
  • 28.Tamura, G. S., M. Herndon, J. Przekwas, C. E. Rubens, P. Ferrieri, and S. L. Hillier. 2000. Analysis of restriction fragment length polymorphisms of the insertion sequence IS1381 in group B streptococci. J. Infect. Dis. 181:364-368. [DOI] [PubMed] [Google Scholar]
  • 29.Wastfelt, M., M. Stalhammar-Carlemalm, A. M. Delisse, T. Cabezon, and G. Lindahl. 1996. Identification of a family of streptococcal surface proteins with extremely repetitive structure. J. Biol. Chem. 271:18892-18897. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES